Sodium glucose cotransporter 2 inhibitors and the risk of respiratory outcomes among patients with type 2 diabetes: A nationwide cohort study

被引：0
|
作者：
Jeong, Han Eol [1 ]
Park, Sohee [2 ]
Noh, Yunha [3 ]
Filion, Kristian [4 ]
Yu, Oriana Hoi Yun [4 ]
Jang, Seung Hun [5 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Seoul, South Korea
[2] SKKU, Sch Pharm, Seoul, South Korea
[3] Sungkunkwan Univ, Seoul, South Korea
[4] McGill Univ, Montreal, PQ, Canada
[5] Hallym Univ, Coll Med, Hallym Univ Sacred Heart Hosp, Dept Internal Med, Chunchon, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
728
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [1] Sodium-glucose cotransporter 2 inhibitors and risk of fractures in postmenopausal women with type 2 diabetes: A nationwide cohort study
    Ko, Hwa Yeon
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 81 - 82
  • [2] Risk of hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Chang, Yoosoo
    Sinn, Dong Hyun
    Yu, Oriana Hoi Yun
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 7 - 8
  • [3] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [4] Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Yu, Oriana H. Y.
    Chang, Yoosoo
    Cho, Juhee
    Sinn, Dong Hyun
    Cho, Young Min
    Shin, Ju-Young
    GUT, 2023, 72 (05) : 1020 - 1022
  • [5] Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
    Jeong, Han Eol
    Park, Sohee
    Noh, Yunha
    Bea, Sungho
    Filion, Kristian B.
    Yu, Oriana H. Y.
    Jang, Seung Hun
    Cho, Young Min
    Yon, Dong Keon
    Shin, Ju-Young
    BMC MEDICINE, 2023, 21 (01)
  • [6] Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
    Han Eol Jeong
    Sohee Park
    Yunha Noh
    Sungho Bea
    Kristian B. Filion
    Oriana H. Y. Yu
    Seung Hun Jang
    Young Min Cho
    Dong Keon Yon
    Ju-Young Shin
    BMC Medicine, 21
  • [7] Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 28 - 36
  • [8] Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort study
    Horii, Takeshi
    Oikawa, Yoichi
    Kunisada, Narumi
    Shimada, Akira
    Atsuda, Koichiro
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (01) : 42 - 46
  • [9] Psychiatric disorders in patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors—a nationwide retrospective cohort study
    Wei-Syun Hu
    Cheng-Li Lin
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 575 - 581
  • [10] Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary C.
    Zakoul, Heidi
    Wexler, Deborah J.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (03) : 265 - 274
12345